This category covers advanced treatments such as CAR-T cell therapy, which modifies immune cells to target disease. Progress in these therapies is expanding options for conditions that can be difficult to treat with conventional medicines.
AAV gene therapy vectors are engineered adeno-associated viruses used to deliver genetic material into cells for therapeutic purposes.
CAR-T cell therapy is a cancer treatment that engineers a patient’s or donor’s T cells to recognize and attack cells bearing a specific target.
mRNA therapeutics use messenger RNA to direct cells to produce a therapeutic protein or trigger a therapeutic immune response.
RNAi therapeutics are treatments that use RNA interference to selectively reduce the expression of specific genes.
Discover and track organizations, patents, publications, grants, news and more. Get live alerts on new startups, funding rounds and emerging developments.
This site uses cookies to ensure you get the best experience. You can manage our different cookies in the settings below. Cookies Policy